4th Quarter - Report

DAVIS & HARMAN LLP for EMERGENT BIOSOLUTIONS, INC.

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

H.R. 4903/S. 2534, Department of Homeland Security Appropriations -- provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Labor HHS -- provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 83, Consolidated and Further Continuing Appropriations Act.

LobbyistCovered position, as disclosed
THOMAS A DAVIS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4903 (113th), H.R. 83 (113th), S. 2534 (113th)

Budget/Appropriations BUD

H.R. 4903/S. 2534, Department of Homeland Security Appropriations -- provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Labor HHS -- provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 83, Consolidated and Further Continuing Appropriations Act.

LobbyistCovered position, as disclosed
THOMAS A DAVIS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4903 (113th), H.R. 83 (113th), S. 2534 (113th)

Health Issues HCR

H.R. 4903/S. 2534, Department of Homeland Security Appropriations -- provisions related to development, acquisition and stockpiling of biodefense vaccines. Department of Labor HHS -- provisions related to development, acquisition and stockpiling of biodefense vaccines. H.R. 83, Consolidated and Further Continuing Appropriations Act.

LobbyistCovered position, as disclosed
THOMAS A DAVIS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4903 (113th), H.R. 83 (113th), S. 2534 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.